Following an eight-week interval i.m. vaccination regimen, mice were challenged eight days after MVA boost, which corresponds to the approximate peak of CD8+ T cell immunogenicity20, with 1000 chimeric sporozoites injected intravenously (i.v.)to focus the challenge to a liver-stage infection. Here, CD8A is linked to infection.